DGX

SEC source: 0001022079-22-000039 · wf-form4_164609580400204.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,405

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

SEC source: 0001022079-22-000037 · wf-form4_164609567521992.xml · derivative · entry 2

Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,529

Underlying: Common Stock · 47,529 shares

Expires 2032-02-24

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-22-000037 · wf-form4_164609567521992.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,282

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · derivative · entry 4

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,654

Underlying: Common Stock · 2,654 shares

Expires 2032-02-24

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,408

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000035 · wf-form4_164609535746556.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,276

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000033 · wf-form4_164609505201179.xml · derivative · entry 2

GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,932

Underlying: Common Stock · 10,932 shares

Expires 2032-02-24

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-22-000033 · wf-form4_164609505201179.xml · nonDerivative · entry 1

GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,676

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000029 · wf-form4_164609475469781.xml · derivative · entry 3

EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,009

Underlying: Common Stock · 19,009 shares

Expires 2032-02-24

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-22-000029 · wf-form4_164609475469781.xml · nonDerivative · entry 2

EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,176

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000029 · wf-form4_164609475469781.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,346

F1 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000031 · wf-form4_164609488034289.xml · derivative · entry 4

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,301

Underlying: Common Stock · 13,301 shares

Expires 2032-02-24

F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

SEC source: 0001022079-22-000031 · wf-form4_164609488034289.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,885

F2 · security: Represents an award of restricted share units.

SEC source: 0001022079-22-000031 · wf-form4_164609488034289.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,144

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020.

SEC source: 0001022079-22-000011 · wf-form4_164583359620758.xml · nonDerivative · entry 2

EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,431

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-22-000011 · wf-form4_164583359620758.xml · nonDerivative · entry 1

EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,882

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000023 · wf-form4_164583456974219.xml · nonDerivative · entry 2

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,709

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000023 · wf-form4_164583456974219.xml · nonDerivative · entry 1

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,964

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000021 · wf-form4_164583433812398.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,813

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000021 · wf-form4_164583433812398.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,219

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000019 · wf-form4_164583422190891.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,727

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

F2 · balance_after: The amount includes approximately 169 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant.

F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-22-000019 · wf-form4_164583422190891.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,640

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000017 · wf-form4_164583402858760.xml · nonDerivative · entry 2

GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,425

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000017 · wf-form4_164583402858760.xml · nonDerivative · entry 1

GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,119

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000013 · wf-form4_164583380035294.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,495

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000013 · wf-form4_164583380035294.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,219

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000015 · wf-form4_164583391573361.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,155

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000015 · wf-form4_164583391573361.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,647

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

SEC source: 0001022079-22-000002 · wf-form4_164133222107425.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,631.404

Underlying: Common Stock · 247 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · derivative · entry 8

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,565 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 6

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,729

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

F6 · price: This transaction was executed in multiple trades at prices ranging from $157.27 to $158.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 5

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,304

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

F5 · price: This transaction was executed in multiple trades at prices ranging from $156.27 to $157.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 4

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,212

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $155.26 to $156.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 3

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,744

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $154.21 to $155.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,994

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $153.21 to $153.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000146 · wf-form4_163839444899069.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,294

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sales reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021.

SEC source: 0001022079-21-000135 · wf-form4_163346605371662.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,336.621

Underlying: Common Stock · 288 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

SEC source: 0001022079-21-000124 · wf-form4_162923239169903.xml · nonDerivative · entry 1

Doi Tracey · CIK 0001527766 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 905

F1 · security: Represents an award of restricted share units granted on August 16, 2021.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · derivative · entry 9

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,193 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · derivative · entry 8

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,193

Underlying: Common Stock · 5,300 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 6

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,427

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

F4 · price: This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 5

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 288,620

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 4

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,427

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 3

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 289,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · derivative · entry 7

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,493

Underlying: Common Stock · 139,751 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 2

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,427

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-21-000117 · wf-form4_162767612798957.xml · nonDerivative · entry 1

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021.

SEC source: 0001022079-21-000113 · wf-form4_162750349054685.xml · derivative · entry 7

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,111 shares

Expires 2023-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.

SEC source: 0001022079-21-000113 · wf-form4_162750349054685.xml · derivative · entry 6

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,111 shares

Expires 2022-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.

SEC source: 0001022079-21-000113 · wf-form4_162750349054685.xml · nonDerivative · entry 4

WILENSKY GAIL R · CIK 0001018538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,845

F2 · price: This transaction was executed in multiple trades at prices ranging from $139.26 to $139.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.